What this is
- How it works
- How it works isn't classified yet
- Tested for
- Lumbosacral Radicular Pain
- Main trialPhase 3
- “This is a research study of SP-102, an experimental medication designed to relieve pain in patients with moderate to severe sciatica (pain in the lower back, hips, buttocks and legs). SP-102, placebo (a medication that looks like SP-102 but does not contain any active ingredient), or an active comparator (dexamethasone sodium phosphate) is given once by the participant's healthcare professional. If a participant meets qualifications, each participant will have the option of receiving one supplemental open-label injection of SP-102, greater than four weeks and up to twenty weeks after their…”In the company’s words, NCT07579351 on ClinicalTrials.gov
Other drugs for Lumbosacral Radicular Pain
- C-1101Consano Bio · Phase 1
Coming up1
- Nov 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | Nov 2028 | Corticosteroid Lumbar Epidural Analgesia for Radicular Pain 2 | |
| Phase 2Completed | 15 Mar 2019 | A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102 |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026